Evidence map›Paper›PMID 37749976›Full record

ArticleBJPsych open2023

Healthcare costs for young people transitioning the boundary between child/adolescent and adult mental health services in seven European countries: results from the MILESTONE study.

Alastair Canaway, Rebecca Appleton, Larissa van Bodegom, Gwen Dieleman, Tomislav Franić, Suzanne Gerritsen, Giovanni de Girolamo, Athanasios Maras, Fiona McNicholas, Mathilde Overbeek and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJPsych open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Alastair CanawayCentre for Health Economics at Warwick, Warwick Medical School, University of Warwick, UK.
Rebecca AppletonNIHR Mental Health Policy Research Unit, Division of Psychiatry, University College London, UK.
Larissa van BodegomYulius Academy, Yulius Mental Health Organization, The Netherlands; and Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, The Netherlands.
Gwen DielemanDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, The Netherlands.
Tomislav FranićDepartment of Psychiatry, University Hospital Split, Croatia; and School of Medicine, University of Split, Croatia.
Suzanne GerritsenDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, The Netherlands.
Giovanni de GirolamoUnit of Epidemiological Psychiatry and Evaluation, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Italy.ORCID https://orcid.org/0000-0002-1611-8324
Athanasios MarasYulius Academy, Yulius Mental Health Organization, The Netherlands; and Department of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, The Netherlands.
Fiona McNicholasSchool of Medicine and Medical Science, University College Dublin, Republic of Ireland; and Lucena Child and Adolescent Mental Health Services, St. John of God Community Services, Republic of Ireland.
Mathilde OverbeekYulius Academy, Yulius Mental Health Organization, The Netherlands and Clinical Child and Family Studies, Faculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, The Netherlands.
Moli PaulWarwick Medical School, University of Warwick, UK and Children and Young People's Mental Health Service, Coventry and Warwickshire Partnership NHS Trust, Coventry, UK.
Diane Purper-OuakilChild and Adolescent Psychiatry Unit, Centre Hospitalier Universitaire de Montpellier, Saint Eloi Hospital, France; and Team PsyDev, CESP U1018, INSERM, Université de Versailles Saint-Quentin-en-Yvelines, University Paris Saclay, France.
Paramala SantoshDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases, South London and Maudsley NHS Foundation Trust, UK; and HealthTracker Ltd, UK.ORCID https://orcid.org/0000-0003-4830-5893
Ulrike SchulzeDepartment of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Germany.
Swaran P SinghWarwick Medical School, University of Warwick, UK and Children and Young People's Mental Health Service, Coventry and Warwickshire Partnership NHS Trust, Coventry, UK.ORCID https://orcid.org/0000-0003-3454-2089
Cathy StreetWarwick Medical School, University of Warwick, UK.
Priya TahWarwick Medical School, University of Warwick, UK.
Bie TremmeryDepartment of Neurosciences, KU Leuven, Belgium.
Helena TuomainenWarwick Medical School, University of Warwick, UK.ORCID https://orcid.org/0000-0003-1636-8187
Frank C VerhulstDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus Medical Center, The Netherlands; and Department of Clinical Medicine, University of Copenhagen, Denmark.
Dieter WolkeDepartment of Psychology, University of Warwick, UK.
Jason MadanCentre for Health Economics at Warwick, Warwick Medical School, University of Warwick, UK.ORCID https://orcid.org/0000-0003-4316-1480
MILESTONE Consortium

Funding

FP7 Health 602442
6 · The paper itself

Abstract

backgroundThe boundary between services for children and adolescents and adults has been identified as problematic for young people with mental health problems.

aimsTo examine the use and cost of healthcare for young people engaged in mental healthcare before and after the child/adolescent and adult service boundary.

methodData from 772 young people in seven European countries participating in the MILESTONE trial were analysed. We analysed and costed healthcare resources used in the 6-month period before and after the service boundary.

resultsThe proportion of young people engaging with healthcare services fell substantially after crossing the service boundary (associated costs €7761 pre-boundary

conclusionsCosts of healthcare are large in this population, but fall considerably after transition, particularly for those who were most severely ill. In part, this is likely to reflect improvement in the mental health of young people. However, qualitative evidence from the MILESTONE study suggests that lack of capacity in adult services and young people's disengagement with formal mental health services post-transition are contributing factors. Long-term data are needed to assess the adverse long-term effects on costs and health of this unmet need and disengagement.

Indexed as

cost of illnessEuropeMental health servicesrandomised controlled trialtransition

Identifiers

PMID37749976
PMCPMC10617498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.